Wordt geladen...
A111 INFLIXIMAB FOR INDUCTION OF REMISSION IN CROHN’S DISEASE
BACKGROUND: Crohn’s disease (CD) is a chronic idiopathic disease characterized by transmural inflammation of the gastrointestinal tract. AIMS: To evaluate the efficacy and safety of infliximab (IFX) for induction of remission in CD. METHODS: MEDLINE, EMBASE, the Cochrane Library were searched from d...
Bewaard in:
| Gepubliceerd in: | J Can Assoc Gastroenterol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507942/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.112 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|